51-105 - Issuers Quoted in the U.S. Over-the-Counter Markets [MI Proposed - Lapsed]

Concurrently Published:

• 51-105CP - Issuers Quoted in the U.S. Over-the-Counter Markets [CP Proposed - Lapsed]
• 51-105F1 - Notice - OTC Issuer Ceases to be an OTC Reporting Issuer [F Proposed - Lapsed]
• 51-105F2 - Notice of Promotional Activities [F Proposed - Lapsed]
• 51-105F3A - Personal Information Form and Authorization of Indirect Collection, Use and Disclosure of Personal Information [F Proposed - Lapsed]
• 51-105F3B - Personal Information Form and Authorization of Indirect Collection, Use and Disclosure of Personal Information [F Proposed - Lapsed]
• 51-105F4 - Notice - Issuer Ceases to be an OTC Reporting Issuer [F Proposed - Lapsed]
• BCN 2011/13 - Publication for Comment of Proposed Multilateral Instrument 51-105 Issuers Quoted in the U.S. Over-the-Counter Markets [BCN - Lapsed]

PART 1 – DEFINITIONS AND REPORTING ISSUER DESIGNATION AND DETERMINATION
1. Definitions
2. National Instrument definitions apply
3. Reporting issuer designation and determination
4. Ceasing to be an OTC reporting issuer

PART 2 – DISCLOSURE
5. Additional disclosure requirements
6. Timely disclosure obligations
7. Registration statement
8. Promotional activities
9. Technical reports – mineral properties
10. Personal information form and authorization

PART 3 – RESALE OF PRIVATE PLACEMENT SECURITIES
11. Resale of seed stock
12. Legends on seed stock
13. Resale of private placement securities acquired after ticker-symbol date
14. No other hold periods

PART 4 – OTHER RESTRICTIONS
15. Securities for services
16. Take-over bid
17. Insider reports

PART 5 – EXEMPTION
18. Exemption

PART 6 – TRANSITION AND COMING INTO FORCE
19. Transition – financial disclosure for non-SEC filers
20. Coming into force